Florida Cancer Specalists — Bradenton, Florida

Florida Cancer Specalists is a clinical research site located in Bradenton, Florida, United States 34209.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Florida Cancer Specalists has participated in 1 clinical trials.

Therapeutic areas: Prostate Cancer.

Sponsors: Agennix.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Bradenton

Browse all research sites in Florida · View every site in Bradenton

• Manatee Hospital / Nova Clinical Research Center
• Nova Clinical Research Centers/Manatee Memorial Hospital
• NOVA Southeastern University
• University of South Florida
• Manatee Memorial Hospital
• Nova Clinical Research at HCA Florida Blake Hospital
• Bradenton Cardiology, Manatee Memorial Hospital
• HCA Florida Blake Hospital
• Bradenton Research Center
• Florida Clinical Research Center
• Meridien Research
• Research Site

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Florida Cancer Specalists?

Florida Cancer Specalists has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Florida Cancer Specalists conducted?

Florida Cancer Specalists has 1 clinical trials on record. Their work covers Prostate Cancer.

Is Florida Cancer Specalists accredited by Crixeo Clinical Trials?

Florida Cancer Specalists has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Florida Cancer Specalists?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.